Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Polycom Inc (PLCM)

Polycom Inc (NASDAQ:PLCM) was in 30 hedge funds’ portfolio at the end of the first quarter of 2013. PLCM shareholders have witnessed an increase in hedge fund sentiment in recent months. There were 25 hedge funds in our database with PLCM positions at the end of the previous quarter.

In today’s marketplace, there are dozens of indicators investors can use to analyze their holdings. A duo of the best are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite money managers can outpace the market by a healthy margin (see just how much).

Polycom Inc (PLCM)Equally as key, optimistic insider trading sentiment is another way to break down the marketplace. There are plenty of stimuli for an executive to get rid of shares of his or her company, but just one, very simple reason why they would behave bullishly. Plenty of academic studies have demonstrated the market-beating potential of this method if investors understand what to do (learn more here).

Keeping this in mind, it’s important to take a glance at the key action surrounding Polycom Inc (NASDAQ:PLCM).

Hedge fund activity in Polycom Inc (NASDAQ:PLCM)

Heading into Q2, a total of 30 of the hedge funds we track were long in this stock, a change of 20% from the first quarter. With hedge funds’ sentiment swirling, there exists an “upper tier” of key hedge fund managers who were upping their stakes substantially.

When looking at the hedgies we track, Omega Advisors, managed by Leon Cooperman, holds the most valuable position in Polycom Inc (NASDAQ:PLCM). Omega Advisors has a $108.7 million position in the stock, comprising 1.7% of its 13F portfolio. Sitting at the No. 2 spot is Mason Capital Management, managed by Kenneth Mario Garschina, which held a $51.4 million position; the fund has 1.3% of its 13F portfolio invested in the stock. Other peers that hold long positions include Matthew Knauer and Mina Faltas’s Nokota Management, Cliff Asness’s AQR Capital Management and Malcolm Fairbairn’s Ascend Capital.

Consequently, key hedge funds have been driving this bullishness. Mason Capital Management, managed by Kenneth Mario Garschina, created the most outsized position in Polycom Inc (NASDAQ:PLCM). Mason Capital Management had 51.4 million invested in the company at the end of the quarter. Christopher Lord’s Criterion Capital also made a $13.5 million investment in the stock during the quarter. The other funds with brand new PLCM positions are SAC Subsidiary’s CR Intrinsic Investors, Ken Grossman and Glen Schneider’s SG Capital Management, and Scott Fine and Peter Richards’s Empire Capital Management.

How are insiders trading Polycom Inc (NASDAQ:PLCM)?

Insider trading activity, especially when it’s bullish, is at its handiest when the company in question has seen transactions within the past half-year. Over the latest half-year time frame, Polycom Inc (NASDAQ:PLCM) has experienced zero unique insiders purchasing, and 3 insider sales (see the details of insider trades here).

With the returns exhibited by the aforementioned time-tested strategies, retail investors should always pay attention to hedge fund and insider trading sentiment, and Polycom Inc (NASDAQ:PLCM) is no exception.

Click here to learn why you should track hedge funds

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!